241 – 250 of 304
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2007
-
Mark
Three-year outcome of Galantamine treatment in Alzheimer’s disease in a routine clinical setting.
(2007) IPA (International Psychogeriatric Association) 2007 Osaka Silver Congress
- Contribution to conference › Poster
-
Mark
Effects of Alzheimer's peptide and alpha1-antichymotrypsin on astrocyte gene expression
(2007) In Neurobiology of Aging
- Contribution to journal › Article
-
Mark
Plasma and CSF serpins in Alzheimer disease and dementia with Lewy bodies
- Contribution to journal › Article
-
Mark
Longitudinal stability of CSF biomarkers in Alzheimer's disease
- Contribution to journal › Article
-
Mark
Cerebrospinal fluid biomarkers predict decline in subjective cognitive function over 3 years in healthy elderly
- Contribution to journal › Article
- 2006
-
Mark
Vagus nerve stimulation in patients with Alzheimer's disease: Additional follow-up results of a pilot study through 1 year.
- Contribution to journal › Article
-
Mark
Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study.
- Contribution to journal › Article
-
Mark
CSF Biomarkers for Alzheimer's Disease: Levels of beta-Amyloid, Tau, Phosphorylated Tau Relate to Clinical Symptoms and Survival.
- Contribution to journal › Article
-
Mark
Changes in the activity and protein levels of CSF acetylcholinesterases in relation to cognitive function of patients with mild Alzheimer's disease following chronic donepezil treatment
- Contribution to journal › Article
-
Mark
Two-year outcome of Galantamine treatment in Alzheimer’s disease in a routine clinical setting.
(2006) 9th International Geneva/Springfield Symposium on Advances in Alzheimer Therapy
- Contribution to conference › Poster
